Good Clinical Practices for the Management of Post-Stroke Spasticity with BoNT-A: A Delphi-Based Approach from the Italian Expert Group. [PDF]
Baricich A +7 more
europepmc +1 more source
RTP004 Peptide Binds to Botulinum Neurotoxin, Increases Cell Surface Binding, and Enhances Cellular SNAP-25 Cleavage. [PDF]
Batista AF +5 more
europepmc +1 more source
Marginal Orbicularis Oris Hyperactivity (MOOH): An Exploratory Case Series of Inversion-Dominant Upper Lip Dynamics Following Intraoral Botulinum Toxin Type A. [PDF]
Armenti AF.
europepmc +1 more source
Neurophysiological Assessment of F-Wave, M-Wave, and Cutaneous Silent Period in Patients with Caput-Pattern Cervical Dystonia at Waning and Peak Response Phases of Botulinum Toxin Therapy. [PDF]
Drużdż A +5 more
europepmc +1 more source
Evaluation of a Cell-Based Potency Assay for Detection of the Potency of TrenibotulinumtoxinE® (TrenibotE). [PDF]
Yang Y, Zhang H, Wang S, Xue Y, Yuan L.
europepmc +1 more source
Botulinum Toxin Injections for Drooling Improve Dysphagia in Patients with Parkinson's Disease. [PDF]
Restivo DA +7 more
europepmc +1 more source
Intramuscular neural distribution of the soleus for botulinum neurotoxin injection: application to spasticity. [PDF]
Yi KH, Hu H, Hwang SO, Lee JH, Lee HJ.
europepmc +1 more source
Longitudinal, Multi-Cycle Evaluation of Passive Function Improvement in People with Arm Spasticity Treated with Botulinum Toxin A. [PDF]
Ashford SA +7 more
europepmc +1 more source
Botulinum Toxin Treatment in Hereditary Spastic Paraplegia-A Comprehensive Review and Update. [PDF]
Jabbari B, Comtesse S, Tavassoli F.
europepmc +1 more source
Why, When, and How to Treat Dynamic Forehead Lines with Botulinum Toxin Type A. [PDF]
de Sanctis Pecora C +3 more
europepmc +1 more source

